Core Roic vs Capex To Revenue Analysis

CLB Stock  USD 20.28  0.72  3.68%   
Core Laboratories financial indicator trend analysis is way more than just evaluating Core Laboratories prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Core Laboratories is a good investment. Please check the relationship between Core Laboratories Roic and its Capex To Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Roic vs Capex To Revenue

Roic vs Capex To Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Core Laboratories Roic account and Capex To Revenue. At this time, the significance of the direction appears to have strong relationship.
The correlation between Core Laboratories' Roic and Capex To Revenue is 0.73. Overlapping area represents the amount of variation of Roic that can explain the historical movement of Capex To Revenue in the same time period over historical financial statements of Core Laboratories NV, assuming nothing else is changed. The correlation between historical values of Core Laboratories' Roic and Capex To Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Roic of Core Laboratories NV are associated (or correlated) with its Capex To Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Revenue has no effect on the direction of Roic i.e., Core Laboratories' Roic and Capex To Revenue go up and down completely randomly.

Correlation Coefficient

0.73
Relationship DirectionPositive 
Relationship StrengthSignificant

Roic

Return on Invested Capital, a profitability ratio that measures the return that an investment generates for those who have provided capital, such as debt holders and equity holders.

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.
Most indicators from Core Laboratories' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Core Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
As of December 11, 2024, Selling General Administrative is expected to decline to about 34.6 M. In addition to that, Tax Provision is expected to decline to about 4 M
 2021 2022 2023 2024 (projected)
Gross Profit83.8M78.9M94.0M171.1M
Total Revenue470.3M489.7M509.8M619.3M

Core Laboratories fundamental ratios Correlations

0.810.590.860.410.820.80.520.70.540.93-0.150.540.730.540.850.680.75-0.290.90.230.820.340.440.840.57
0.810.610.65-0.180.741.00.370.340.440.81-0.290.440.530.170.990.360.64-0.450.980.060.580.440.510.520.51
0.590.610.81-0.110.240.550.860.620.710.380.040.710.840.160.620.130.51-0.840.7-0.120.750.20.230.430.49
0.860.650.810.310.520.60.810.910.820.63-0.020.820.930.570.680.560.77-0.60.790.040.960.050.210.80.66
0.41-0.18-0.110.310.31-0.170.130.520.090.360.110.090.280.67-0.110.660.180.33-0.020.310.37-0.10.030.570.1
0.820.740.240.520.310.770.080.30.260.91-0.390.260.320.50.770.650.490.040.760.30.450.450.320.690.43
0.81.00.550.6-0.170.770.310.30.380.82-0.340.380.480.190.990.370.62-0.410.960.050.530.420.540.50.51
0.520.370.860.810.130.080.310.770.750.210.210.750.940.280.380.230.55-0.840.5-0.070.86-0.160.170.430.4
0.70.340.620.910.520.30.30.770.760.440.080.760.890.660.390.60.69-0.470.520.00.92-0.130.070.750.58
0.540.440.710.820.090.260.380.750.760.260.11.00.810.560.440.440.48-0.670.55-0.050.82-0.11-0.110.670.56
0.930.810.380.630.360.910.820.210.440.26-0.320.260.450.420.850.590.62-0.040.850.230.550.50.530.710.51
-0.15-0.290.04-0.020.11-0.39-0.340.210.080.1-0.320.10.18-0.18-0.330.14-0.310.05-0.280.660.15-0.1-0.420.13-0.68
0.540.440.710.820.090.260.380.750.761.00.260.10.810.560.440.440.48-0.670.55-0.050.82-0.11-0.110.670.56
0.730.530.840.930.280.320.480.940.890.810.450.180.810.470.550.480.67-0.720.660.060.97-0.040.20.670.48
0.540.170.160.570.670.50.190.280.660.560.42-0.180.560.470.230.780.39-0.10.31-0.010.57-0.26-0.070.770.55
0.850.990.620.68-0.110.770.990.380.390.440.85-0.330.440.550.230.380.68-0.440.990.030.60.460.530.560.57
0.680.360.130.560.660.650.370.230.60.440.590.140.440.480.780.380.350.070.440.490.640.02-0.030.860.18
0.750.640.510.770.180.490.620.550.690.480.62-0.310.480.670.390.680.35-0.430.74-0.140.730.040.310.540.68
-0.29-0.45-0.84-0.60.330.04-0.41-0.84-0.47-0.67-0.040.05-0.67-0.72-0.1-0.440.07-0.43-0.50.43-0.60.17-0.24-0.12-0.48
0.90.980.70.79-0.020.760.960.50.520.550.85-0.280.550.660.310.990.440.74-0.50.030.710.40.490.640.62
0.230.06-0.120.040.310.30.05-0.070.0-0.050.230.66-0.050.06-0.010.030.49-0.140.430.030.160.29-0.310.41-0.61
0.820.580.750.960.370.450.530.860.920.820.550.150.820.970.570.60.640.73-0.60.710.16-0.020.150.790.5
0.340.440.20.05-0.10.450.42-0.16-0.13-0.110.5-0.1-0.11-0.04-0.260.460.020.040.170.40.29-0.020.140.170.0
0.440.510.230.210.030.320.540.170.07-0.110.53-0.42-0.110.2-0.070.53-0.030.31-0.240.49-0.310.150.14-0.040.37
0.840.520.430.80.570.690.50.430.750.670.710.130.670.670.770.560.860.54-0.120.640.410.790.17-0.040.42
0.570.510.490.660.10.430.510.40.580.560.51-0.680.560.480.550.570.180.68-0.480.62-0.610.50.00.370.42
Click cells to compare fundamentals

Core Laboratories Account Relationship Matchups

Core Laboratories fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets774.7M568.6M580.9M578.4M586.4M550.2M
Short Long Term Debt Total381.8M327.0M250.3M222.4M215.4M220.2M
Other Current Liab50.8M34.9M28.5M31.8M32.4M46.3M
Total Current Liabilities111.6M89.8M90.8M103.1M88.1M100.6M
Total Stockholder Equity182.1M75.6M161.0M189.0M224.8M131.8M
Property Plant And Equipment Net199.2M181.7M172.3M157.4M153.5M120.1M
Net Debt370.7M313.2M232.6M207.0M200.3M187.0M
Retained Earnings160.5M50.5M68.3M85.9M120.8M194.2M
Accounts Payable35.6M23.0M29.7M45.8M33.5M35.9M
Cash11.1M13.8M17.7M15.4M15.1M14.4M
Non Current Assets Total553.4M402.7M391.8M366.7M363.3M325.2M
Non Currrent Assets Other(71.3M)(76.9M)(74.6M)(73.0M)98.6M103.5M
Cash And Short Term Investments11.1M13.8M17.7M15.4M15.1M14.4M
Net Receivables131.6M83.2M96.8M106.9M123.1M129.1M
Common Stock Shares Outstanding44.6M45.0M46.7M46.8M47.5M40.8M
Liabilities And Stockholders Equity774.7M568.6M580.9M578.4M586.4M550.2M
Non Current Liabilities Total480.9M403.3M329.1M286.3M268.5M267.2M
Inventory50.2M38.2M45.4M60.4M71.7M39.7M
Other Current Assets28.4M30.7M29.1M28.9M13.2M26.0M
Other Stockholder Equity26.8M27.1M97.0M100.9M108.6M114.0M
Total Liab592.5M493.0M419.9M389.4M356.6M367.8M
Property Plant And Equipment Gross199.2M181.7M172.3M157.4M469.3M492.7M
Total Current Assets221.2M165.8M189.1M211.7M223.1M225.0M
Accumulated Other Comprehensive Income(6.3M)(7.2M)(10.1M)(3.8M)(5.0M)(5.2M)
Short Term Debt11.8M11.4M12.3M11.7M10.2M14.1M
Intangible Assets17.5M8.6M8.1M7.5M6.9M6.6M
Other Liab109.9M87.7M91.1M75.6M86.9M66.4M
Other Assets119.4M179.4M107.7M102.3M1.00.95
Long Term Debt305.3M259.4M188.6M172.4M163.1M227.7M
Property Plant Equipment123.5M115.3M172.3M157.4M181.0M126.1M
Current Deferred Revenue13.4M5.5M7.8M5.9M4.8M4.5M
Treasury Stock(29.4M)(14.1M)(4.1M)(1.4M)(1.6M)(1.6M)
Net Tangible Assets11.7M19.6M(58.5M)115.6M104.1M109.3M
Noncontrolling Interest In Consolidated Entity4.3M4.1M4.6M4.7M5.4M4.6M
Retained Earnings Total Equity160.5M50.5M68.3M85.9M77.4M73.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.316
Dividend Share
0.04
Earnings Share
0.54
Revenue Per Share
11.158
Quarterly Revenue Growth
0.072
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.